India’s drug regulator, the CDSCO, has issued a safety advisory for thyroid patients, warning of potentially life-threatening side effects from carbimazole and doxycycline. Manufacturers have also been directed to update packaging with clear warnings.
The study findings were published in the Journal of Clinical Investigation. Globally, an estimated 10 million people develop tuberculosis (TB) each year and the disease remains a leading cause of death from a single infectious agent.
